Berberine is sold online as a natural alternative to prescription weight-loss drugs, usually on evidence far thinner than the marketing. A randomised, double-blind, placebo-controlled trial published in Nutrients tested a fixed combination of berberine, white mulberry leaf extract and chromium picolinate in 93 Greek adults with obesity over 12 weeks, and found real differences against … Read more
If you take a GLP-1 drug and have an operation booked, this is the study to know about. Across 119 UK hospitals and 47,039 patients, regurgitation or stomach contents entering the lungs happened to about 1 in 71 people taking a GLP-1 drug, against about 1 in 802 of everyone else. The events clustered at … Read more
Eli Lilly posted the full results of ACHIEVE-3 to ClinicalTrials.gov on 15 September 2026, and they are the first detailed head-to-head numbers between the two oral GLP-1 drugs. Over 52 weeks in 1,698 adults with type 2 diabetes, the higher dose of orforglipron lowered blood sugar further than the higher dose of oral semaglutide and … Read more
Adolescents with obesity who started semaglutide, liraglutide or tirzepatide were less likely to have a recorded suicide-related event over up to three years than matched adolescents managed with lifestyle intervention, according to an electronic health records study published on 14 September in Diabetes, Obesity and Metabolism. It points away from psychiatric harm in the age … Read more
The FDA on 15 September 2026 told consumers not to buy or use two products sold for weight loss, LUZE Fit Intensity and Beauty 911, after its laboratory found sibutramine in both. Neither label lists it. Sibutramine was the active ingredient in Meridia, a prescription weight-loss drug whose approval the FDA withdrew in 2010 after … Read more
Nine people reported fever, chills, chest pain or vomiting after receiving compounded injections that a Houston pharmacy has now recalled nationwide. Centric Compounding is pulling six lots of glutathione, Myer’s Cocktail and Tri-Immune Boost, injectables sold to support immunity, fatigue and general wellness, after the glutathione raw ingredient used to make them was found to … Read more
A weight-loss supplement sold directly to consumers online has been recalled nationwide after FDA laboratory testing found two undeclared drugs inside the same box. The daytime tablets of Lipofit Extreme Fat Burner 2.0 contained fluoxetine, a prescription antidepressant. The nighttime tablets contained 2,4-dinitrophenol, a substance the FDA describes as a pesticide, dye, wood preservative and … Read more
The European Association for the Study of Obesity has published a position statement whose argument is not about whether incretin drugs work. It treats that as settled. The argument is that everything around the prescription has failed to keep pace: patient selection, monitoring, clinician training and access have all moved more slowly than the drugs, … Read more